Mentor Corporation (NYSE: MNT) 17% LOWER; expects Fiscal 2007 sales of $300 million to $302 million. The Company had previously guided that sales would be in the range of $305 million to $315 million. The consensus is $309.3 million. Mentor sees 2008 sales of $340 million to $355 million. The consensus is $371.9 million.
Robert Half (NYSE: RHI) 11% LOWER; reports Q1 EPS of $0.42, 4 cents worse than estimates.(0.46) Revenues were $1.1 billion vs. $1.10 billion consensus.
Stamps.com (Nasdaq: STMP) 8% LOWER; reports Q1 EPS of $0.14, in-line with estimates.(0.14) Revenues were $20.00 million vs. $21.59 million consensus. Sees FY EPS between $0.67-0.77 vs. consensus of $0.77.
Energy Conversion Devices, Inc. (ECD Ovonics) (Nasdaq: ENER) 7% LOWER; implementing an organizational restructuring plan to consolidate and realign its business activities and reduce annual costs by approximately $23 million. The company will incur restructuring and other related charges in the fourth quarter of the current fiscal year of $3 – 6 million, with additional charges in fiscal year 2008. Sees Q3 EPS of $27 million, which compares to the consensus of $32.6 million.
Nabi Biopharmaceuticals (Nasdaq: NABI) 6% HIGHER; executed a definitive agreement to sell its Aloprim for Injection product to Bioniche Teoranta. Bioniche Teoranta is based in Ireland and is part of Bioniche Pharma Group. The aggregate sale proceeds for Aloprim is $3.7 million.
Informatica (Nasdaq: INFA) 6% HIGHER; reports Q1 EPS of $0.15, 3 cents better than estimates.(0.12) Revenues were $87.1 million vs. $84.75 million consensus. Company approves $50 million stock buyback.
Capital One (NYSE: COF) 5.8% LOWER; reports Q1 EPS of $1.62, 37 cents worse than estimates.(1.99) Company revises FY EPS to between $7.00-7.40 vs. consensus of $7.71
Advanced Micro Devices (NYSE: AMD) 4% HIGHER; reports a Q1 loss of $0.90 (ex-items), 42 cents worse than estimates.(-.48) Revenues were $1.23 billion vs. $1.26 billion consensus. On the call, the company said they see some stabilization in pricing.
Oakley (NYSE: OO) 4% HIGHER; reports Q1 EPS of $0.08, 5 cents better than estimates.(0.03) Revenues were $199.2 million vs. $181.25 million consensus. Sees FY EPS of $0.95-0.98 vs. $0.96 consensus.
Intuitive Surgical (Nasdaq: ISRG) 3% HIGHER; reports Q1 EPS of $0.62, 9 cents better than estimates.(0.53) Revenues were $114.2 million vs. $110.74 million consensus.
Aeroflex Incorporated (Nasdaq: ARXX) 3% HIGHER; received from Veritas Capital a non-binding proposal, subject to due diligence and other conditions, for a leveraged recapitalization of Aeroflex in which Aeroflex’s stockholders would receive a cash dividend of $14 per share and retain in the aggregate 21.2% of the fully diluted common equity in a significantly leveraged Aeroflex.
Mentor Corporation (NYSE: MNT) 17% LOWER; expects Fiscal 2007 sales of $300 million to $302 million. The Company had previously guided that sales would be in the range of $305 million to $315 million. The consensus is $309.3 million. Mentor sees 2008 sales of $340 million to $355 million. The consensus is $371.9 million.
Robert Half (NYSE: RHI) 11% LOWER; reports Q1 EPS of $0.42, 4 cents worse than estimates.(0.46) Revenues were $1.1 billion vs. $1.10 billion consensus.
Stamps.com (Nasdaq: STMP) 8% LOWER; reports Q1 EPS of $0.14, in-line with estimates.(0.14) Revenues were $20.00 million vs. $21.59 million consensus. Sees FY EPS between $0.67-0.77 vs. consensus of $0.77.
Energy Conversion Devices, Inc. (ECD Ovonics) (Nasdaq: ENER) 7% LOWER; implementing an organizational restructuring plan to consolidate and realign its business activities and reduce annual costs by approximately $23 million. The company will incur restructuring and other related charges in the fourth quarter of the current fiscal year of $3 – 6 million, with additional charges in fiscal year 2008. Sees Q3 EPS of $27 million, which compares to the consensus of $32.6 million.
Nabi Biopharmaceuticals (Nasdaq: NABI) 6% HIGHER; executed a definitive agreement to sell its Aloprim for Injection product to Bioniche Teoranta. Bioniche Teoranta is based in Ireland and is part of Bioniche Pharma Group. The aggregate sale proceeds for Aloprim is $3.7 million.
Informatica (Nasdaq: INFA) 6% HIGHER; reports Q1 EPS of $0.15, 3 cents better than estimates.(0.12) Revenues were $87.1 million vs. $84.75 million consensus. Company approves $50 million stock buyback.
Capital One (NYSE: COF) 5.8% LOWER; reports Q1 EPS of $1.62, 37 cents worse than estimates.(1.99) Company revises FY EPS to between $7.00-7.40 vs. consensus of $7.71
Advanced Micro Devices (NYSE: AMD)4% HIGHER; reports a Q1 loss of $0.90 (ex-items), 42 cents worse than estimates.(-.48) Revenues were $1.23 billion vs. $1.26 billion consensus. On the call, the company said they see some stabilization in pricing.
Oakley (NYSE: OO) 4% HIGHER; reports Q1 EPS of $0.08, 5 cents better than estimates.(0.03) Revenues were $199.2 million vs. $181.25 million consensus. Sees FY EPS of $0.95-0.98 vs. $0.96 consensus.
Intuitive Surgical (Nasdaq: ISRG) 3% HIGHER; reports Q1 EPS of $0.62, 9 cents better than estimates.(0.53) Revenues were $114.2 million vs. $110.74 million consensus.
Aeroflex Incorporated (Nasdaq: ARXX) 3% HIGHER; received from Veritas Capital a non-binding proposal, subject to due diligence and other conditions, for a leveraged recapitalization of Aeroflex in which Aeroflex’s stockholders would receive a cash dividend of $14 per share and retain in the aggregate 21.2% of the fully diluted common equity in a significantly leveraged Aeroflex.
http://www.streetinsider.com/Special+Reports
Credit Card Companies Are Doing Something Nuts
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
